Cargando…
Orally Available Selective Melanocortin-4 Receptor Antagonists Stimulate Food Intake and Reduce Cancer-Induced Cachexia in Mice
BACKGROUND: Cachexia is among the most debilitating and life-threatening aspects of cancer. It represents a metabolic syndrome affecting essential functional circuits involved in the regulation of homeostasis, and includes anorexia, fat and muscle tissue wasting. The anorexigenic peptide α-MSH is be...
Autores principales: | Weyermann, Philipp, Dallmann, Robert, Magyar, Josef, Anklin, Corinne, Hufschmid, Martina, Dubach-Powell, Judith, Courdier-Fruh, Isabelle, Henneböhle, Marco, Nordhoff, Sonja, Mondadori, Cesare |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2654097/ https://www.ncbi.nlm.nih.gov/pubmed/19295909 http://dx.doi.org/10.1371/journal.pone.0004774 |
Ejemplares similares
-
The orally active melanocortin-4 receptor antagonist BL-6020/979: a promising candidate for the treatment of cancer cachexia
por: Dallmann, R., et al.
Publicado: (2011) -
NQO1-Dependent Redox Cycling of Idebenone: Effects on Cellular Redox Potential and Energy Levels
por: Haefeli, Roman H., et al.
Publicado: (2011) -
Safety of TCMCB07, a melanocortin‐4 antagonist peptide, in dogs with naturally occurring cachexia
por: Axiak‐Bechtel, Sandra M., et al.
Publicado: (2023) -
Val103Ile polymorphism of the melanocortin-4 receptor gene (MC4R) in cancer cachexia
por: Knoll, Susanne, et al.
Publicado: (2008) -
Genetic and pharmacologic blockade of central melanocortin signaling attenuates cardiac cachexia in rodent models of heart failure
por: Scarlett, Jarrad M, et al.
Publicado: (2010)